South Korean Scientists Develop H1N1 Flu Vaccine

Scientists from South Korea say they have succeeded in developing human vaccines against influenza A (H1N1) that can be used to cut the spread of the disease.
The researchers from Chungnam National University say they have been propagating "virus standard" supplied by the Center for Disease Control and Prevention (CDC) United States and create a material that is not toxic and can be mass produced cheaply.

The research team headed by Seo Sang-heui say it with a vaccine CNUK-RG A/CA/4xPR/8 (H1N1), was developed on Friday, eleven days after the CDC provide the virus samples.

Scientists have done tests on samples of human and monkey cells. Fully developed vaccine will be marketed in September after a clinical experiments completed.